14-91234353-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001177676.2(GPR68):āc.698C>Gā(p.Thr233Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000203 in 1,578,790 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 32)
Exomes š: 0.000020 ( 0 hom. )
Consequence
GPR68
NM_001177676.2 missense
NM_001177676.2 missense
Scores
3
5
11
Clinical Significance
Conservation
PhyloP100: 6.93
Genes affected
GPR68 (HGNC:4519): (G protein-coupled receptor 68) The protein encoded by this gene is a G protein-coupled receptor for sphingosylphosphorylcholine. The encoded protein is a proton-sensing receptor, inactive at pH 7.8 but active at pH 6.8. Mutations in this gene are a cause of amelogenesis imperfecta. [provided by RefSeq, Feb 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22690219).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPR68 | NM_001177676.2 | c.698C>G | p.Thr233Ser | missense_variant | 2/2 | ENST00000650645.1 | NP_001171147.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPR68 | ENST00000650645.1 | c.698C>G | p.Thr233Ser | missense_variant | 2/2 | NM_001177676.2 | ENSP00000498702 | P1 | ||
GPR68 | ENST00000531499.2 | c.698C>G | p.Thr233Ser | missense_variant | 2/2 | 1 | ENSP00000434045 | P1 | ||
GPR68 | ENST00000535815.5 | c.698C>G | p.Thr233Ser | missense_variant | 2/2 | 1 | ENSP00000440797 | P1 | ||
GPR68 | ENST00000529102.1 | c.698C>G | p.Thr233Ser | missense_variant | 2/2 | 1 | ENSP00000432740 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152272Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
152272
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000520 AC: 10AN: 192336Hom.: 0 AF XY: 0.0000286 AC XY: 3AN XY: 104958
GnomAD3 exomes
AF:
AC:
10
AN:
192336
Hom.:
AF XY:
AC XY:
3
AN XY:
104958
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000203 AC: 29AN: 1426400Hom.: 0 Cov.: 33 AF XY: 0.0000184 AC XY: 13AN XY: 707586
GnomAD4 exome
AF:
AC:
29
AN:
1426400
Hom.:
Cov.:
33
AF XY:
AC XY:
13
AN XY:
707586
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152390Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74522
GnomAD4 genome
AF:
AC:
3
AN:
152390
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74522
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
9
Asia WGS
AF:
AC:
13
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 13, 2023 | The c.698C>G (p.T233S) alteration is located in exon 2 (coding exon 1) of the GPR68 gene. This alteration results from a C to G substitution at nucleotide position 698, causing the threonine (T) at amino acid position 233 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;.
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
D;D;D
Sift4G
Benign
T;T;D
Polyphen
D;D;.
Vest4
MutPred
Gain of catalytic residue at T233 (P = 0.0028);Gain of catalytic residue at T233 (P = 0.0028);Gain of catalytic residue at T233 (P = 0.0028);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at